Conrad En Zuo Chan (Conrad E Z Chan)

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Venues

NPJ vaccines

Influenza and other respiratory viruses

Journal of medical virology

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Charmaine W Y Chew, Barnaby E Young, Paul A Tambyah, Shawn Vasoo, Conrad En Zuo Chan
Bidirectional Evolution of SARS-CoV-2 Virus in Immunocompromised Hosts. Influenza and other respiratory viruses 18 (3) (2024)
Charmaine W Y Chew, Barnaby E Young, Paul A Tambyah, Shawn Vasoo, Conrad En Zuo Chan
Bidirectional Evolution of SARS-CoV-2 Virus in Immunocompromised Hosts. Influenza and other respiratory viruses 18 (3) (2024)
De Hoe Chye, Charmaine W Y Chew, He Ping Yeo, Paul A Tambyah, Barnaby E Young, Gladys G Y Tan, Boon Huan Tan, Shawn Vasoo, Conrad En Zuo Chan
Neutralization escape of emerging subvariants XBB.1.5/1.9.1 and XBB.2.3 from current therapeutic monoclonal antibodies. Journal of medical virology 95 (9) (2023)
Shivankari Krishnananthasivam, Hao Li, Rania Bouzeyen, Bhuvaneshwari Shunmuganathan, Kiren Purushotorman, Xinlei Liao, Fengjiao Du, Claudia Guldager Kring Friis, Felicity Crawshay-Williams, Low Heng Boon, Qian Xinlei, Conrad En Zuo Chan, Radoslaw Mikolaj Sobota, Mary Kozma, Valeria Barcelli Jo, Guirong Wang, Hairong Huang, R Andres Floto, Pablo Bifani, Babak Javid, Paul Anthony MacAry
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis. NPJ vaccines 8 (1) (2023)
Shivankari Krishnananthasivam, Hao Li, Rania Bouzeyen, Bhuvaneshwari Shunmuganathan, Kiren Purushotorman, Xinlei Liao, Fengjiao Du, Claudia Guldager Kring Friis, Felicity Crawshay-Williams, Low Heng Boon, Qian Xinlei, Conrad En Zuo Chan, Radoslaw Mikolaj Sobota, Mary Kozma, Valeria Barcelli Jo, Guirong Wang, Hairong Huang, R Andres Floto, Pablo Bifani, Babak Javid, Paul Anthony MacAry
Author Correction: An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis. NPJ vaccines 8 (1) (2023)
Saket Jhajharia, Fritz Lai, Heng Boon Low, Kiren Purushotorman, Bhuvaneshwari D/O Shunmuganathan, Conrad En Zuo Chan, Rachel Hammond, Hans-Jürgen Netter, Qingfeng Chen, Seng Gee Lim, Paul Anthony MacAry
Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus. NPJ vaccines 7 (1) (2022)
Conrad En Zuo Chan, Steven K K Wong, Nurhidayah Binte M Yazid, Oon Tek Ng, Kalisvar Marimuthu, Monica Chan, Hwee Siew Howe, Yee Sin Leo, Bernard P Leung, Shawn S Vasoo, Barnaby E Young
Residual humoral immunity sustained over decades in a cohort of vaccinia-vaccinated individuals. The Journal of infectious diseases (2022)
Venkateshan S Prativadibhayankaram, Lawrence Soon-U Lee, David Lye, Xu Xiaoying, Ranjani Nellore, Vishal Pendharkar, Hannes Hentze, Siyu Guan, Benjamin J Ayers, Shirley G K Seah, De Hoe Chye, Najwa S N Talib, Nivashini Kaliaperumal, Wei Yee Ong, Zi Xin Wong, Veonice B Au, Anshula Alok, John E Connolly, Jerome D Boyd-Kirkup, Piers J Ingram, Brendon J Hanson, Kantharaj Ethirajulu, Damian O'Connell, Conrad En Zuo Chan
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults. Infectious diseases and therapy 11 (5) (2022)

Conrad En Zuo Chan.css-eqlu8i{font-size:small;padding-left:4px;} (Conrad E Z Chan)

Publication Activity (10 Years)

Top Topics

Top Venues

Conrad En Zuo Chan (Conrad E Z Chan)